Device Trial Radar · NCT06070389
Polysomnography Validation of the Sansa Device
Last checked: Nov 21, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
533
Actual
Start
Jun 1, 2023
Primary completion
Dec 13, 2023
Study completion Dec 13, 2023
Sponsor
- Lead sponsor
- Huxley Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 6, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the performance of the Sansa device for the diagnosis of sleep disordered breathing.
Conditions
- Sleep-Disordered Breathing
Interventions
Sansa deviceDevice
The Sansa device will be used during a single overnight polysomnography study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity and Specificity of the Sansa device to detect sleep disordered breathing compared to polysomnographyTime frame: 1 night
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Pulmonary & Sleep Specialists
Decatur, Georgia
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.